Episode 69 – Hypertension and Heart Failure

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Drs. Emily Hughes and Justin Boyle discuss two recent papers exploring a novel agent, Zilebesiran, in the management of hypertension and the use of Semaglutide in patients that have obesity and heart failure with preserved ejection fraction. Two papers, here we go!

  1. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension (0:00 – 10:10).

  2. Semaglutide in Patients with Heart Failurewith Preserved Ejection Fraction and Obesity (10:10 – 20:18).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more